Exogenous induction of cerebral β-amyloidosis in βAPP-transgenic mice

Peptides

Volumn 23, Issue 7, 2002, Pages 1241-1247

  Walker, Lary C ^a   Callahan, Michael J ^a   Bian, Feng ^a   Durham, Robert A ^a   Roher, Alex E ^b   Lipinski, William J ^a  

^a PFIZER INC   (United States)

^b SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

A ; Alzheimer; Amyloid; Angiopathy; Conformational disease; Neurodegeneration; Prion; Proteopathy; Senile plaque; Spongiform encephalopathy; Tau

Indexed keywords

AMYLOID PRECURSOR PROTEIN; INDIAN INK; TAU PROTEIN;

ADULT; ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CASE REPORT; CELL AGGREGATION; CELL TRANSPORT; CONTROLLED STUDY; CORPUS CALLOSUM; ENTORHINAL CORTEX; FOREBRAIN; HEMISPHERE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INCUBATION TIME; INNERVATION; MALE; MICROGLIA; MOUSE; NERVE FIBER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SENILE PLAQUE; TRANSGENIC MOUSE; ANIMAL; BRAIN CORTEX; CHEMICALLY INDUCED DISORDER; CYTOLOGY; GENETICS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; TIME;

AMYLOID BETA-PROTEIN PRECURSOR; AMYLOIDOSIS; ANIMAL; AXONS; CEREBRAL CORTEX; CORPUS CALLOSUM; ENTORHINAL CORTEX; HUMAN; INJECTIONS, INTRAVENTRICULAR; MICE; MICE, TRANSGENIC; MICROGLIA; TIME FACTORS; ANIMALS; HUMANS;

MUS MUSCULUS;

EID: 0035997227     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(02)00059-1     Document Type: Article

References (37)

1. Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis
2. Induction of β(A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy
3. Mechanisms of cerebrovascular amyloid deposition. Lessons from mouse models
4. Augmented senile plaque load in aged female β-amyloid precursor protein-transgenic mice
5. Conformational disease
6. Spontaneous generation of infectious nucleating amyloids in the transmissible and non-transmissible cerebral amyloidoses
7. Blood buffy coat from Alzheimer's disease patients and their relatives does not transmit spongiform encephalopathy to hamsters
8. Evidence for and against the transmissibility of Alzheimer disease
9. Genetic dissection of Alzheimer's disease and related dementias: Amyloid and its relationship to tau
10. Correlative memory deficits Aβ, elevation, and amyloid plaques in transgenic mice
11. Protein precipitation: A common etiology in neurodegenerative disorders?
12. Evidence for seeding of β-amyloid by intracerebral infusion of Alzheimer brain extracts in β-amyloid precursor protein-transgenic mice
13. The role of inflammatory cells in the pathogenesis of amyloidosis
14. Kinetics of amyloid deposition. I. The effects of amyloid-enhancing factor and splenectomy
15. Amyloid diseases: Abnormal protein aggregation in neurodegeneration
16. Structural neurology: Are seeds at the root of neuronal degeneration?
17. Naturally occurring and experimentally induced β-amyloid deposits in the brains of marmosets (Callithrix jacchus)
18. Transgenic animal models of Alzheimer disease
19. Genetic neurodegenerative diseases: The human illness and transgenic models
20. The prion diseases
21. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication
22. Biology of β-amyloid precursor protein and the mechanism of Alzheimer disease
23. Experimental study of amyloid formation
24. Recent advances in transgenic model development for Alzheimer's disease
25. Association of microglia with amyloid plaques in brains of APP23 transgenic mice
26. Cells of origin of entorhinal cortical afferents to the hippocampus and fascia dentata of the rat
27. The organization of the embryonic, commissural, and septal connections studied with the lipophilic tracer DiI
28. Cerebral amyloid angiopathy in aged dogs and non-human primates
29. The neurobiology of aging in non-human primates
30. The cerebral proteopathies
31. The cerebral proteopathies: Neurodegenerative disorders of protein conformation and assembly
32. Apolipoprotein E4 promotes the early deposition of Aβ42 and then Aβ40 in the elderly
33. Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly
34. Microglial cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plaque degradation
35. The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APPsw mice
36. The prionoses and other conformational disorders